RxDoctor Payments Data

Jennifer Rhea

Nurse Practitioner · Jackson, MSNPI 1568651289

Payments from drug & device makers

$1,703in general payments, 2019–2025

Across 88 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$353
  • Pfizer$309
  • Boston Scientific$177
  • AstraZeneca$168
  • Merck$154
  • Inspire Medical Systems, Inc.$107
  • plus $435 from 10 others

What the payments were for

  • Food & beverage$1,703100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,703 in reported general payments places this provider in the 80th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$66,343
Medicare patients
317
Services billed
925

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban186$135,555
EntrestoSacubitril/Valsartan99$127,550
FarxigaDapagliflozin Propanediol92$85,186
JardianceEmpagliflozin54$47,215
XareltoRivaroxaban12$9,809
BrilintaTicagrelor15$6,348
Metoprolol Succinate255$2,609
Diltiazem 24hr Er (Cd)Diltiazem Hcl72$1,275
Terazosin Hcl69$925
Losartan Potassium80$749
Atorvastatin Calcium96$735
Nifedipine ErNifedipine32$679
Amiodarone Hcl20$642
Valsartan12$522
Amlodipine Besylate93$500

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$309$135,555186 claims
NovartisEntresto$353$127,55099 claims
AstraZenecaFarxiga, Brilinta$168$91,534107 claims
Boehringer IngelheimJardiance$50$47,21554 claims
Johnson & JohnsonXarelto$21$9,80912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →